Replies to post #1264 on CTI BioPharma Corp (fka CTIC)

[I Like Bottom Fishing]

Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Tuesday, March 24, 2009

Tuesday , March 24, 2009 01:30ET

http://www.knobias.com/story.htm?eid=3.1.adc5e5d289c5af187427d7325d3cfcf7465a4ee6001b9a6d3a1fdaafbbef2332

SEATTLE, March 24 /PRNewswire-FirstCall/ -- On Tuesday, March 24, 2009, at 6:00 PM Central European Time/1:00 PM Eastern Time/10:00 AM Pacific Time members of Cell Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) management team will host a Special Meeting in lieu of the Annual Meeting of Shareholders at its Seattle headquarters located at 501 Elliott Ave. West, Seattle, WA 98119. The meeting will be webcast live on CTI's website at http://www.CellTherapeutics.com and archived for replay.

Special Meeting in lieu of Annual Meeting of Shareholders
Tuesday, March 24

Conference Call

10:00 AM Pacific / 1:00 PM Eastern / 6:00 PM CET
1-800-218-8862 (US Participants)
1-303-228-2960 (International)


Call-back numbers for post listening:
1-800-405-2236 (US Participants)
1-303-590-3000 (International)
Passcode: 11125470#

Live webcast with slides at
http://www.CellTherapeutics.com
Archived for post viewing approximately 2 hours after the meeting ends

Media Contact:
Cell Therapeutics, Inc.
Dan Eramian
T: 206.272.4343
C: 206.854.1200
F: 206.272.4434
E: [e-mail]
www.celltherapeutics.com/media.htm

Investors Contact:
Cell Therapeutics, Inc.
Ed Bell
T: 206.272.4345
Lindsey Jesch
T: 206.272.4347
F: 206.272.4434
E: [e-mail]
www.celltherapeutics.com/investors.htm

SOURCE Cell Therapeutics, Inc.

Contacts:

Media
Dan Eramian
206-272-4343
Cell
206-854-1200
Fax
206-272-4434
[e-mail]

Investors, Ed Bell
206-272-4345
Lindsey Jesch
206-272-4347
Fax
206-272-4434
[e-mail]

all of Cell Therapeutics, Inc.


Public Companies Associated with this story:
CTIC

Knobias Subject Codes Associated with this story:
Conference Call Shareholder Issues

Content provided by PR Newswire Copyright © 2009
Content transmitted by Knobias.com Copyright © 2009 Visit Knobias.com

http://www.knobias.com/story.htm?eid=3.1.adc5e5d289c5af187427d7325d3cfcf7465a4ee6001b9a6d3a1fdaafbbef2332

ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER
Copyright © 2009 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.